A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population (Nephrology Dialysis Transplantation, 2024)

(untitled) - Forbes, AK; Hinton, W; Feher, MD; Elson, W; Ordóñez-Mena, JM; Joy, M; Fan, X; Banerjee, D; Cole, NI; Munro, N; Whyte, M; Suckling, RJ; et al.